Showing 521 - 540 results of 662 for search '"neurodegenerative diseases"', query time: 0.05s Refine Results
  1. 521
  2. 522
  3. 523
  4. 524
  5. 525

    Meeting Challenges in the Diagnosis and Treatment of Glaucoma by Karanjit S. Kooner, Dominic M. Choo, Priya Mekala

    Published 2024-12-01
    “…Glaucoma, a progressive and multifactorial optic neurodegenerative disease, still poses significant challenges in both diagnosis and management and remains a perpetual enigma [...]…”
    Get full text
    Article
  6. 526
  7. 527
  8. 528

    Autonomic Dysfunctions in Parkinson’s Disease: Prevalence, Clinical Characteristics, Potential Diagnostic Markers, and Treatment by Zhe Zhang, Sheng-Di Chen

    Published 2020-01-01
    “…Parkinson’s disease (PD) is a common neurodegenerative disease in the middle-aged and the elderly. …”
    Get full text
    Article
  9. 529

    RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and Neurodegeneration by Scott E. Ugras, James Shorter

    Published 2012-01-01
    “…Amyotrophic Lateral Sclerosis (ALS) is an adult onset neurodegenerative disease, which is universally fatal. While the causes of this devastating disease are poorly understood, recent advances have implicated RNA-binding proteins (RBPs) that contain predicted prion domains as a major culprit. …”
    Get full text
    Article
  10. 530

    Satellite microglia: marker of traumatic brain injury and regulator of neuronal excitability by Alicia B. Feichtenbiner, Karinn Sytsma, Ryan P. O’Boyle, Rhonda Mittenzwei, Heather Maioli, Kathryn P. Scherpelz, Daniel D. Child, Ning Li, Jeanelle Ariza Torres, Lisa Keene, Amanda Kirkland, Kimberly Howard, Caitlin Latimer, C. Dirk Keene, Christopher Ransom, Amber L. Nolan

    Published 2025-01-01
    “…Abstract Traumatic brain injury is a leading cause of chronic neurologic disability and a risk factor for development of neurodegenerative disease. However, little is known regarding the pathophysiology of human traumatic brain injury, especially in the window after acute injury and the later life development of progressive neurodegenerative disease. …”
    Get full text
    Article
  11. 531

    Controllability of Functional and Structural Brain Networks by Ali Moradi Amani, Amirhessam Tahmassebi, Andreas Stadlbauer, Uwe Meyer-Baese, Vincent Noblet, Frederic Blanc, Hagen Malberg, Anke Meyer-Baese

    Published 2024-01-01
    “…Describing the nature of these interactions has been a challenging task yet important for neurodegenerative disease evolution. Fusing modern dynamic graph network theory techniques and control theory applied on complex brain networks creates a new framework for neurodegenerative disease research by determining disease evolution at the subject level, facilitating a predictive treatment response and revealing key mechanisms responsible for disease alterations. …”
    Get full text
    Article
  12. 532

    Nonconvulsive Status Epilepticus on Electroencephalography: An Atypical Presentation of Subacute Sclerosing Panencephalitis in Two Children by Pratibha Singhi, Arushi Gahlot Saini, Jitendra Kumar Sahu

    Published 2012-01-01
    “…Subacute sclerosing panencephalitis is a neurodegenerative disease secondary to measles infection that usually has a typical presentation with progressive myoclonia, cognitive decline, and periodic slow-wave complexes on electroencephalography. …”
    Get full text
    Article
  13. 533
  14. 534
  15. 535

    Cystatin C Secretion in Blood Derivatives and Cellular Models of Idiopathic Parkinson’s Disease by Kathleen Mommaerts, Anna S. Monzel, Alise Zagare, Sarah L. Nickels, Nico J. Diederich, Laura Longhino, William Mathieson, Paul M. A. Antony, Fay Betsou, Jens C. Schwamborn

    Published 2025-01-01
    “…Both neuroprotective and neurodegenerative roles have been suggested for cystatin C in neurodegenerative disease. In Parkinson’s disease, investigations assessing cystatin C levels in different types of biospecimens such as blood, cerebrospinal fluid, and in vitro models have had conflicting results. …”
    Get full text
    Article
  16. 536
  17. 537

    A human-induced pluripotent stem cell (iPSC) line (SMUSHi006-A) from an ALS patient carrying a mutation c.1126C > T in the FUS gene by Chunyan Huang, Liying Qiu, Wenyan Zhou, Congwen Shao, Xichun Wang, Qiwen Zhang, Weilin Chen, Min Xiong, Min Huang, Mei Tang, Liangyu Zou, Xueqing Xu

    Published 2025-02-01
    “…Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease. Four major genes associated with ALS—SOD1, TARDBP, FUS, and C9orf72—have been identified, with the fused in sarcoma (FUS) gene demonstrating considerable genetic heterogeneity. …”
    Get full text
    Article
  18. 538

    Mechanisms of Neuroprotection by Protein Disulphide Isomerase in Amyotrophic Lateral Sclerosis by Adam K. Walker, Julie D. Atkin

    Published 2011-01-01
    “…Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterised by the progressive loss of motor neurons, leading to paralysis and death within several years of onset. …”
    Get full text
    Article
  19. 539
  20. 540

    Genetic Rat Models of Parkinson's Disease by Ryan M. Welchko, Xavier T. Lévêque, Gary L. Dunbar

    Published 2012-01-01
    “…Parkinson’s disease (PD) is a neurodegenerative disease characterized by a specific loss of dopaminergic neurons. …”
    Get full text
    Article